１，桑原義和, 馬場泰輔, 王　ル, 村田和浩, 栗原　愛, 海老島茂子, 山本陽一郎, 福本　学:放射線耐性を理解する上での問題点. 放射線生物研究.41:380-6,2006.

​

２，福本　学:ヒト放射線発がんと放射線耐性の分子機構の解明. 東北大学医学部保健学科紀要. 17(1):1-8, 2008.

​

３，Kuwahara Y, Li L, Baba T, Nakagawa H, Shimura T, Yamamoto Y, Ohkubo Y, Fukumoto M: Clinically relevant radioresistant cells efficiently repair DNA double-strand breaks induced by X-rays. Cancer Sci 100(4):747-52, 2009. (doi: 10.1111/j.1349-7006.2009.01082.x)

​

４，Kuwahara Y, Mori M, Oikawa T, Shimura T, Ohtake Y, Mori S, Ohkubo Y, Fukumoto M: The modified high-density survival assay is the useful tool to predict the effectiveness of fractionated radiation exposure. J Radiat Res 51(3):297-302, 2010.

​

５，Kuwahara Y, Oikawa T, Ochiai Y, Roudkenar MH, Fukumoto M, Shimura T, Ohtake Y, Ohkubo Y, Mori S, Uchiyama Y, Fukumoto M: Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy. Cell Death Dis 2:e177, 2011. (doi: 10.1038/cddis.2011.56)

​

６，桑原義和, 福本　基, 及川利幸, 森美由紀, 志村　勉, 大竹洋輔, 大久保恭仁, 内山安男, 福本　学: X線照射後のがん細胞で見られる様々な細胞死. 放射線生物研究. 46(3):271-82, 2011.

 

７，福本　学: 放射線病理学: トロトラスト症から. 病理と臨床. 29(7):761-8, 2011.

​

８，Kuwahara Y, Mori M, Kitahara S, Fukumoto M, Ezaki T, Mori S, Echigo S, Ohkubo Y, Fukumoto M: Targeting of tumor endothelial cells combining 2 Gy/day of X-ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors. Cancer Med 3(2):310-21, 2014.( doi: 10.1002/cam4.185)

​

９，Fukumoto M, Amanuma T, Kuwahara Y, Shimura T, Suzuki M, Mori S, Kumamoto H, Saito Y, Ohkubo Y, Duan Z, Sano K, Oguchi T, Kainuma K, Usami S, Kinoshita K, Lee I, Fukumoto M: Guanine nucleotide-binding protein 1 is one of the key molecules contributing to cancer cell radioresistance. Cancer Sci 105(10):1351-9, 2014. (doi: 10.1111/cas.12489)

​

１０，Fukumoto M: Radiation pathology: From thorotrast to the future beyond radioresistance. Pathol Int 64(6):251-62. 2014. (doi: 10.1111/pin.12170)

​

１１，Saito Y, Abiko R, Kishida A, Kuwahara Y, Yamamoto Y, Yamamoto F, Fukumoto M, Ohkubo Y: Loss of EGF-dependent cell proliferation ability on radioresistant cell HepG2-8960-R. Cell Biochem Funct 33(2):73-9, 2015. (doi: 10.1002/cbf.3090)

​

１２，Kuwahara Y, Roudkenar MH, Suzuki M, Urushihara Y, Fukumoto M, Saito Y, Fukumoto M: The Involvement of Mitochondrial Membrane Potential in Cross-Resistance Between Radiation and Docetaxel. Int J Radiat Oncol Biol Phys 96(3):556-65, 2016. (doi: 10.1016/j.ijrobp.2016.07.002)

​

１３，Tomita K, Kuwahara Y, Takashi Y, Tsukahara T, Kurimasa A, Fukumoto M, Nishitani Y, Sato T: Sensitivity of mitochondrial DNA depleted ρ0 cells to H2O2 depends on the plasma membrane status. Biochem Biophys Res Commun 490(2):330-335, 2017. (doi: 10.1016/j.bbrc.2017.06.044)

​

１４，Kuwahara Y, Roudkenar MH, Urushihara Y, Saito Y, Tomita K, Roushandeh AM, Sato T, Kurimasa A, Fukumoto M: Med Mol Morphol 50(4):195-204, 2017. (doi: 10.1007/s00795-017-0171-x)

​

１５，桑原義和，富田和男，漆原佑介，齋藤陽平，佐藤友昭，栗政明弘，福本学：2Gy/日のX線分割照射に抵抗性を示すがん細胞の樹立と解析．東北医科薬科大学研究誌．64, 2018.（印刷中）